Jürg Stäubli

Title: Jürg Stäubli: Innovator in Cannabinoid Research

Introduction

Jürg Stäubli is a notable inventor based in Prangins, Switzerland. He has made significant contributions to the field of cannabinoid research, particularly in the conversion of THC, CBD, and their derivatives to Cannabinol. His innovative methods have the potential to impact various applications in the pharmaceutical industry.

Latest Patents

Stäubli holds a patent for a method that aromatizes an alicyclic region of a cannabinoid. This method is particularly focused on enantiopure, scalemic, and racemic forms of cannabinoids. The patent details the process of aromatizing the cyclohexene group in Δ-THC-C, Δ-THCA-CA, Δ-THCV-C, Δ-THCVA-CA, and mixtures of these substances. An oxidizing agent is added to the cannabinoid, with sulfur being utilized as the oxidizing agent.

Career Highlights

Throughout his career, Jürg Stäubli has worked with prominent organizations such as Swiss Cannapharmaceutical SA and ETH Zurich. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Stäubli has collaborated with notable individuals, including Erick Moran Carreira and Roman Sarott. These partnerships have further enhanced his research and development efforts in cannabinoid applications.

Conclusion

Jürg Stäubli's innovative work in cannabinoid research exemplifies the potential of scientific advancements in the pharmaceutical industry. His contributions through patents and collaborations continue to pave the way for future developments in this important field.